The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125016642 12501664 2 F 201406 20160720 20160627 20160727 EXP US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-39980BP BOEHRINGER INGELHEIM 86.38 YR F Y 0.00000 20160727 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125016642 12501664 1 PS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 18 MCG 507914A,15C3219 21395 18 UG INHALATION POWDER, HARD CAPSULE QD
125016642 12501664 2 C LOSARTAN. LOSARTAN 1 Oral 100 MG 0 100 MG QD
125016642 12501664 3 C citalapam 2 Oral 20 MG 0 20 MG QD
125016642 12501664 4 C levothyroxin LEVOTHYROXINE 1 Oral 75 MG 0 75 MG QD
125016642 12501664 5 C NIFEDIPINE. NIFEDIPINE 1 Oral 60 MG 0 60 MG QD
125016642 12501664 6 C ASPIRIN. ASPIRIN 1 Oral 81 MG 0 81 MG QD
125016642 12501664 7 C METOPROLOL. METOPROLOL 1 Oral 10 MG 0 10 MG QD
125016642 12501664 8 C atorvastatin ATORVASTATIN 1 Oral 40 MG 0 40 MG QD
125016642 12501664 9 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Oral 30 MG 0 10 MG TID
125016642 12501664 10 C benzonate BENZONATATE 1 Oral 0 200 MG
125016642 12501664 11 C DULERA FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE 1 Respiratory (inhalation) DOSE PER APPLICATION: 200MCG/5MCG 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125016642 12501664 1 Chronic obstructive pulmonary disease
125016642 12501664 2 Product used for unknown indication
125016642 12501664 3 Depression
125016642 12501664 4 Hypothyroidism
125016642 12501664 5 Hypertension
125016642 12501664 6 Product used for unknown indication
125016642 12501664 7 Hypertension
125016642 12501664 8 Blood cholesterol increased
125016642 12501664 9 Hypertension
125016642 12501664 10 Product used for unknown indication
125016642 12501664 11 Chronic obstructive pulmonary disease

Outcome of event

Event ID CASEID OUTC COD
125016642 12501664 OT
125016642 12501664 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125016642 12501664 Bronchitis
125016642 12501664 Circulatory collapse
125016642 12501664 Dependent personality disorder
125016642 12501664 Dizziness
125016642 12501664 Fall
125016642 12501664 Fatigue
125016642 12501664 Head injury
125016642 12501664 Heart rate decreased
125016642 12501664 Hypertension
125016642 12501664 Hypotension
125016642 12501664 Muscular weakness
125016642 12501664 Nasopharyngitis
125016642 12501664 Pneumonia
125016642 12501664 Product physical issue
125016642 12501664 Product quality issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125016642 12501664 1 2008 0
125016642 12501664 2 2014 0
125016642 12501664 3 2006 0
125016642 12501664 7 2014 0
125016642 12501664 8 2000 0
125016642 12501664 9 201601 0
125016642 12501664 10 201601 0
125016642 12501664 11 201601 0